For many individuals, a daily multivitamin acts as the nutritional foundation of a balanced GLP-1 supplement routine
Companies market them as supplements, but they do not have the clinical testing needed to get medical approval or be used as prescriptions
Concluding, Forsyth predicts a see-saw affect with increasing GLP-1 agonist receptor use prompting a reorientation of category sales as manufacturers realise that consumers are changing what they put in their shopping baskets
Our goal is to give patients multiple evidence-based options so they can choose the treatment that best fits their lifestyle, preferences, health needs, and price point to make long-term use a viable option. Amy Sheer, MD, MPH, DABOM MNT also spoke with George W
In practice, the Australian market includes both single GLP-1 receptor agonists and a dual GIP/GLP-1 agonist
The right choice depends on your health profile Dr